Total Funding
45
70
Total FundingSeries B raised
Growth Score
-27 pts
Heat Score
17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
18027
Tvardi Therapeutics is a Private, Clinical Stage Biotechnology Company.
Ronald A. DePinho: Co-FounderPast Role: Eden Therapeutics, Co-Founder and Director- Jeno Gyuris: Chief Scientific Officer & Chair of Scientific Advisory BoardPast Role: AVEO Oncology, Chief Scientific Officer
About the Company
Tvardi Therapeutics they are focused on the development of orally delivered, small molecule inhibitors of STAT3. They provide medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases.
